Crude Oil WTI traded higher by 0.77% at $61.36/bbl, and Brent was up 0.66% at $63.99/bbl. Unlock your all-in-one trading dashboard with real-time alerts, rankings, and stock ideas-now 60% off for Memorial Day.

It's been a challenging year for NovoCure ( NASDAQ: NVCR ) , an oncology-focused biotech. The stock is down by 35% since early January. Though marketwide issues probably didn't help, NovoCure mostly has itself to blame for its year-to-date performance.

As of May 28, 2025, two stocks in the information technology sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days ...

CAMBRIDGE, Mass., May 28, 2025 ( GLOBE NEWSWIRE ) -- Generation Bio Co. ( Nasdaq:GBIO ) , a biotechnology company working to change what's possible for people living with T cell-driven autoimmune diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will present ...

NEW YORK, May 28, 2025 ( GLOBE NEWSWIRE ) -- OTC Markets Group Inc. OTCM, operator of regulated markets for trading 12,000 U.S. and international securities, today announced that Magna Mining Inc.

Positions ATI as a top supplier to Airbus of titanium flat rolled and long products DALLAS, May 28, 2025 /PRNewswire/ -- ATI Inc. ATI is pleased to announce it has signed a multi-year agreement with Airbus, securing the airframer's supply of titanium plate, sheet and billet as it continues to ...

BOSTON , May 28, 2025 ( GLOBE NEWSWIRE ) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that management will participate in fireside chats during the following investor conferences:

WALTHAM, Mass., May 28, 2025 ( GLOBE NEWSWIRE ) -- TScan Therapeutics, Inc.

90 mg once-daily palazestrant dose selected for Part 2 of the Phase 3 OPERA-01 monotherapy trial and for the Phase 3 OPERA-02 combination trial with ribociclib OPERA-01 trial-in-progress poster to be presented on Monday, June 2 between 9:00am-12:00pm CT / 10:00am-1:00pm ET

BOISE, Idaho, May 28, 2025 /PRNewswire/ - Perpetua Resources Corp. PPTA PPTA ( "Perpetua Resources" or "Perpetua" or the "Company" ) today announced that it has been awarded up to $6.9 million in additional funding from the U.S. Army via the Defense Ordnance Technology Consortium ( "DOTC" ) .